Frazier Management LLC’s Crinetics Pharmaceuticals In Position
Does Frazier Management LLC own Crinetics Pharmaceuticals In (CRNX)? Not currently — the last reported position was 1.38M shares worth $39M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$39M
Q4 2021
Shares
1.38M
% of Portfolio
+3.03%
Quarters Held
2
position exited
Position History CRNX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of CRNX.